How do I subscribe to ongoing alerts?

Subscribe to /feed/company/johnson-johnson-consumer-inc-mcneil-consumer-healthcare-division.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division pipeline: 2 marketed, 0 filed, 7 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 7 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
acetaminophen Caplet	acetaminophen Caplet	marketed
ibuprofen Liquid-filled capsule	ibuprofen Liquid-filled capsule	marketed
Commercial ibuprofen	Commercial ibuprofen	phase 3	Nonsteroidal anti-inflammatory drug (NSAID)	Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2)	Pain Management, Inflammation, Fever
Commercial naproxen sodium tablet	Commercial naproxen sodium tablet	phase 3	Nonsteroidal anti-inflammatory drug (NSAID)	COX-1, COX-2	Pain Management, Inflammation
Commercial acetaminophen	Commercial acetaminophen	phase 3	Analgesic and antipyretic	Cyclooxygenase (COX), primarily in central nervous system	Pain Management
Placebo Liquid-filled capsule	Placebo Liquid-filled capsule	phase 3
Test naproxen sodium tablet	Test naproxen sodium tablet	phase 3	NSAID	COX	Pain management, Inflammation
Test acetaminophen	Test acetaminophen	phase 3	Non-opioid analgesic	COX	Pain relief
Placebo Caplet	Placebo Caplet	phase 3

Therapeutic area mix

Pain Management · 1
Pain Management, Inflammation · 1
Pain Management, Inflammation, Fever · 1
Pain management, Inflammation · 1
Pain relief · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Noven Pharmaceuticals, Inc. · 2 shared drug classes
Pfizer · 2 shared drug classes
Iroko Pharmaceuticals, LLC · 2 shared drug classes
Novartis · 2 shared drug classes
Organon and Co · 2 shared drug classes
Amneal Pharmaceuticals, LLC · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
American University of Beirut Medical Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division:

Cite this brief

Drug Landscape (2026). Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/johnson-johnson-consumer-inc-mcneil-consumer-healthcare-division. Accessed 2026-05-17.